SUBSCRIBE
SUBSCRIBE

Johnson & Johnson Family of Companies

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Two Drugmakers Johnson & Johnson May Consider Scooping Up
April 1, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
1,000+ Women are Suing Johnson & Johnson for Allegedly Covering Up Baby Powder Cancer Risk for Decades
March 31, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Pharm Country
Johnson & Johnson and Roche Could Be the Storm Off Celgene’s Horizon
March 24, 2016
 · 
3 min read
Business
Seattle’s Adaptive Biotech to Base New Business in San Diego with Ex-Johnson & Johnson Exec in Charge
March 18, 2016
 · 
2 min read
Biotech Bay
The 8 Best Pharmaceutical Companies to Work for
Looking for the best pharmaceutical companies to work for? Here’s the list of the top 8 pharma companies that are hiring right now. So, let’s check the list.
March 16, 2016
 · 
8 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Documents Accuse Bayer, Johnson & Johnson of Deceiving The New England Journal of Medicine
March 2, 2016
 · 
2 min read
Pliant Therapeutics Launches in the Bay Area With $45 Million and former Johnson & Johnson and Celgene Execs At the Wheel
Business
Pliant Launches in the Bay Area With $45 Million and Former Johnson & Johnson and Celgene Execs At the Wheel
February 18, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
In Need of Cash, UK’s Shield Therapeutics Could Consider Partnerships with Amgen or Johnson & Johnson
February 16, 2016
 · 
3 min read
Policy
Ex-FDAAdvisoryCommittee.com Head Accused of Conspiring to Suppress Information About Harmful Effects of Johnson & Johnson Antibiotic
February 9, 2016
 · 
2 min read
Load More
AWARDS
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
December 29, 2025
 · 
5 min read
Press Releases
European Commission approves TREMFYA® (guselkumab) for the treatment of children with plaque psoriasis, marking the first paediatric indication for an IL-23 inhibitor
December 22, 2025
 · 
14 min read
Press Releases
Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma
December 19, 2025
 · 
6 min read
Press Releases
U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE® (lazertinib)
December 18, 2025
 · 
33 min read
Press Releases
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results - December 15, 2025
December 16, 2025
 · 
1 min read
Press Releases
Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors
December 16, 2025
 · 
4 min read
Press Releases
U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*
December 15, 2025
 · 
20 min read
Press Releases
Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI®▼ (teclistamab) plus DARZALEX® (daratumumab) subcutaneous formulation as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
December 10, 2025
 · 
18 min read
Press Releases
Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
December 10, 2025
 · 
28 min read
Press Releases
Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 9, 2025
 · 
1 min read
Load More